CN102920977B - Traditional Chinese medicine composition for treating liver cancer - Google Patents
Traditional Chinese medicine composition for treating liver cancer Download PDFInfo
- Publication number
- CN102920977B CN102920977B CN2012103939544A CN201210393954A CN102920977B CN 102920977 B CN102920977 B CN 102920977B CN 2012103939544 A CN2012103939544 A CN 2012103939544A CN 201210393954 A CN201210393954 A CN 201210393954A CN 102920977 B CN102920977 B CN 102920977B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- herba
- rhizoma
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating liver cancer, which is prepared from the following raw materials in part by weight: 24-40 parts of angelica, 9-21 parts of Sichuan radix curcumae, 9-21 parts of radix bupleuri, 15-30 parts of albizia julibrissin, 15-30 parts of radix paeoniae alba, 20-40 parts of herba lycopi, 30-90 parts of radix astragali, 30-60 parts of radix pseudostellariae, 20-40 parts of roasted rhizoma atractylodis macrocephalae, 40-90 parts of semen coicis, 9-15 parts of pericarpium citri reticulatae, 9-15 parts of rhizoma pinelliae, 30-90 parts of rhizoma paridis, 30-90 parts of herba portulacae, 40-90 parts of rhizoma smilacis glabrae, 20-40 parts of herba solani nigri, 30-60 parts of nidus vespae, 30-60 parts of Chinese lobelia, 40-90 parts of spreading hedyotis, 7-18 parts of diverse wormwood herb, 15-40 parts of radix cynanchi paniculati, 30-50 parts of vinegar turtle, 30-60 parts of concha arcae, 15-40 parts of salvia chinensis, 9-30 parts of rhizoma curcumae, 20-40 parts of pharbitis seed, 9-15 parts of fructus aurantii, 9-15 parts of fructus aurantii immaturus, 9-18 parts of herba epimedii, 7-12 parts of radix rehmanniae recens and 6-12 parts of panax pseudoginseng powder (taken after mixed with water). The traditional Chinese medicine composition for treating liver cancer provided by the invention is strict in compatibility of medicines, reasonable in formula and skillful in medication; and according to the years of clinical use, the traditional Chinese medicine composition realizes an obvious curative effect on liver cancer and a satisfactory long-term curative effect, and is an ideal medicine for preventing and treating liver cancer.
Description
Technical field
The present invention relates to technical field of Chinese medicines, be specifically related to a kind of Chinese medicine composition that is used for the treatment of hepatocarcinoma.
Background technology
Hepatocarcinoma is called as " king in cancer " always, patient's condition is dangerous, prognosis is severe, life cycle is short, mortality rate is high, survival rate is low, modern medicine be take and performed the operation as major-minor with chemicotherapy in treatment, Biotherapeutics etc., but because of its grade of malignancy high, though also unavoidable recurrence and transfer after various advanced therapies, it is high that the medicine that is used for the treatment of at present hepatocarcinoma exists cost mostly, toxic and side effects is large, curative effect is low, the shortcoming such as can't effect a radical cure, the medicine of satisfactory effect not yet appears liver cancer treatment is had up to now both at home and abroad, this difficult incurable disease is a unsolved world medicine difficult problem always, research and develop that liver cancer treatment is had to the medicine of significant curative effect is key subjects and the research emphasis of field of medicaments.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine composition that is used for the treatment of hepatocarcinoma.
In order to realize above purpose, the technical solution adopted in the present invention is: a kind of Chinese medicine composition that is used for the treatment of hepatocarcinoma, by the crude drug of following parts by weight, made:
Preferably, the Chinese medicine composition that is used for the treatment of hepatocarcinoma is made by the crude drug of following parts by weight:
Further preferred, the Chinese medicine composition that is used for the treatment of hepatocarcinoma is made by the crude drug of following parts by weight:
The described Chinese medicine composition that is used for the treatment of hepatocarcinoma can be made the pharmaceutically acceptable dosage forms such as decoction, watered pill, capsule, powder, oral liquid, injection.
For the cause of disease of primary hepatocarcinoma, doctor trained in Western medicine is thought has substantial connection with viral hepatitis, liver cirrhosis, aflatoxin or other chemical carcinogens etc.The traditional Chinese medical science thinks that the cause of disease of hepatocarcinoma is dirty, the depression of liver-QI of deficiency of vital QI, seven emotions wound, and qi depression to blood stasis, water damp-phlegm are solidifying, retention of damp-heat in the interior, scorchingly hot gathering, the sick vital QI being weakened and pathogen being violent that belongs to.Liver is the viscus of storing blood, and body is cloudy with sun, and the happiness bar reaches, and dislikes depressed.Liver cancer patient often has irritability stasis, catharsis mistake department, therefore should dispersing the stagnated live-QI to relieve the stagnation of QI, because of liver property to just, necessary soft and moist nourishing, replenishing the kidney(water)to nourish the liver(wood), therefore, with dispersing the stagnated live-QI to relieve the stagnation of QI such as Radix Angelicae Sinensis, RADIX CURCUMAE from Sichuan of China, Flos Albiziae, Radix Bupleuri, the Radix Paeoniae Alba, herba lycopis, must relax irritability, carefree reaches, and QI and blood is logical, and negative and positive are flat; " know the disease of liver, in the ban tonifying the spleen ", thus with harmonizing the liver and stomach, liver spleens such as the Radix Astragali, Radix Pseudostellariae, Rhizoma Atractylodis Macrocephalae (parched), Semen Coicis, Pericarpium Citri Reticulatae, the Rhizoma Pinelliaes, the taste dryness and dampness coordinating each other of make suring, lifting must be taken charge of, and negative and positive are harmonious; The pyretic toxicity knot is poly-, and retention of damp-heat in the interior, therefore with clearing away heat-damp and promoting diuresis, detoxicating and resolving stagnation of pathogens such as Rhizoma Paridis, Herba Portulacae, Rhizoma Smilacis Glabrae, Herba Solani Nigri, Nidus Vespae, Herba Lobeliae Chinensis, Herba Hedyotidis Diffusae, Liu Jiquan, Radix Cynanchi Paniculatis; The solidifying poison knot of expectorant, cancer is as hard stone, therefore capture with hard masses softening and resolving, removing blood stasis such as Carapax Trionycis (processed with vinegar), Concha Arcae, Herba Salviae Chinensis, Rhizoma Curcumae, Semen Pharbitidis, Fructus Aurantii, Fructus Aurantii Immaturuss; The kidney usually involved in chronic disease, the kidney being the origin of congenital constitution, therefore with Herba Epimedii, Radix Rehmanniae the kidney warming activating the spleen, replenishing the kidney(water)to nourish the liver(wood).All medicines share, and by soothing the liver, easing the affected liver, liver heat removing, change liver, suppressing the hyperactive liver, digest by evil all methods, the irritability of make suring must be relaxed, the liver body must soften, liver-fire obtains clearly, the liver stasis of blood must be changed, liver-yang must be put down, can make cancer gesture Blocking and reversion, with spleen invigorating ridging, kidney-reinforcing Yang-strengthening, therefore life is active, stupid cancer obtains Liao again.The Chinese medicine composition compatibility that is used for the treatment of hepatocarcinoma provided by the invention is rigorous, reasonable recipe, medication is ingenious, through clinical use for many years, prove to therapeutic efficacy for hepatic carcinoma definitely, reliably to there is anticancer, enhancing immunologic function, the quality of making the life better, prevent and treat relapse and metastasis, extend the survival of patients phase, even thoroughly effect a radical cure the significant curative effect of hepatocarcinoma.Provided by the inventionly for the Chinese medicine composition of preventing and treating hepatocarcinoma, can apply early in the hepatitis such as hepatitis B, hepatitis C, liver cirrhosis stage, can prevent that it from making progress to hepatocarcinoma, thereby effectively prevent liver cancer occurs.The Chinese medicine composition that is used for the treatment of hepatocarcinoma provided by the invention has no side effect, and more can bring into play anti-recurrence and shift, and the enhanced sensitivity attenuation, improve the quality of living, and extends the effects such as life cycle, for capturing hepatocarcinoma this " king in cancer ", provides desirable control medicine.
The specific embodiment
Embodiment 1
The Chinese medicine composition that is used for the treatment of hepatocarcinoma that the present embodiment provides is made by the crude drug of following parts by weight:
Above crude drug is commercially available Chinese medicine.The Chinese medicine composition that is used for the treatment of hepatocarcinoma that the present embodiment provides is decoction, and its preparation method is with the preparation method of conventional decoction.
Embodiment 2
The Chinese medicine composition that is used for the treatment of hepatocarcinoma that the present embodiment provides is made by the crude drug of following parts by weight:
Above crude drug is commercially available Chinese medicine.The Chinese medicine composition that is used for the treatment of hepatocarcinoma that the present embodiment provides is the watered pill, and its preparation method is with the preparation method of conventional watered pill.
Embodiment 3
The Chinese medicine composition that is used for the treatment of hepatocarcinoma that the present embodiment provides is made by the crude drug of following parts by weight:
Above crude drug is commercially available Chinese medicine.The Chinese medicine composition that is used for the treatment of hepatocarcinoma that the present embodiment provides is capsule, and its preparation method is with the preparation method of conventional capsule.
Embodiment 4
The Chinese medicine composition that is used for the treatment of hepatocarcinoma that the present embodiment provides is made by the crude drug of following parts by weight:
Above crude drug is commercially available Chinese medicine.The Chinese medicine composition that is used for the treatment of hepatocarcinoma that the present embodiment provides is powder, and its preparation method is with the preparation method of conventional powder.
Embodiment 5
The Chinese medicine composition that is used for the treatment of hepatocarcinoma that the present embodiment provides is made by the crude drug of following parts by weight:
Above crude drug is commercially available Chinese medicine.The Chinese medicine composition that is used for the treatment of hepatocarcinoma that the present embodiment provides is oral liquid, and its preparation method is with the preparation method of conventional oral liquid.
The clinical observation on the therapeutic effect of the Chinese medicine composition that is used for the treatment of hepatocarcinoma that test example embodiment 1 provides
1, case choice criteria
Choose Patients with Primary 30 examples, all cases are all clarified a diagnosis and are diagnosed as primary hepatocarcinoma through pathological diagnosis or AFP mensuration, imaging examination etc., and diagnostic criteria is with reference to the diagnostic criteria of hepatocarcinoma in " the Chinese common cancer diagnosis and treatment standard " of national treatment and prevention of tumour office and Chinese Anti-Cancer Association's co-edit.Male's 19 examples wherein, women's 11 examples; Minimum 22 years old, maximum 71 years old, 53 years old mean age; Hepatocarcinoma II phase patient 9 examples, hepatocarcinoma III phase patient 21 examples, previously have Chronic Liver medical history 19 examples, and 28 examples have the obvious enlargement of liver spleen, and 13 examples are associated with jaundice ascites, and all cases all has the treatment history.
2, curative effect determinate standard
Curative effect determinate standard is with reference to disclosed WHO curative effect evaluation standard in generation English chief editor " Clinical Oncology ";
CR: all sings and symptomses disappear fully, time remaining >=1 month;
PR: tumor size estimate to reduce >=50%, time remaining >=1 month;
NC: the state of an illness is without significant change, time remaining >=1 month, and tumor size increases estimates<25%, dwindle<50%;
PD: occur that new focus or original focus increase;
Wherein, CR(complete response): alleviate fully; PR(partial response): partial rcsponse; NC(no change): unchanged; PD(progressive disease): progress.Wherein CR+PR is effective percentage (response rate, RR).
3, Therapeutic Method
Above hepatocarcinoma case is all taken the Chinese medicine composition decoction that is used for the treatment of hepatocarcinoma that the embodiment of the present invention 1 provides, and every day three times, within three months, is a course for the treatment of.
4, observation of curative effect
After the treatment of 2-12 the course for the treatment of, there are 27 conditions of patients to be clearly better, CR totally 10 examples wherein, PR is totally 17 examples, NC 1 example, PD 2 examples, effective percentage is 90.00%.
Result shows, the Chinese medicine composition that is used for the treatment of hepatocarcinoma that the embodiment of the present invention 1 provides is Hepatoma therapy effectively, and clinical efficacy is remarkable.After treatment, AFP also descends or turns out cloudy before treatment, and hypochondriac pain after treatment, weak, abdominal distention, indigestion and loss of appetite each clinical symptoms are obviously improved, and continue to strengthen treatment, and late result is also satisfactory, and after treatment, patient's survival rate is shown in Table 1.
The survival rate of the routine liver cancer patient of table 130 (%)
As can be seen from Table 1, within 5 years, survival rate is 63.33%, within 10 years, survival rate is 36.67%, within 20 years, survival rate 26.67%, and life cycle, the longest strong the depositing of two routine advanced liver cancers reached more than 40 years, proved that the Chinese medicine composition that is used for the treatment of hepatocarcinoma that the embodiment of the present invention 1 provides can improve survival, improve patients ' life quality, can better improve patient's hypochondriac pain, abdominal distention, the clinical symptoms such as weak, indigestion and loss of appetite, extend life cycle, even reach the desirable curative effect of radical cure.Motherland's medicine treasure-house world is exclusive, estimable, and the fact of mid and late liver cancer patient-long-term health existence illustrates effectively the Chinese medicine treatment must aim at the pathogenesis of disease, thoroughly effects a radical cure the superior place of difficult incurable disease.
Model case
Case 1 intelligence, man, 46 years old, first visit on June 17 in 1971.The main suit: the long lump of right abdominal part speed, more than constant pain February.Various big hospital is diagnosed as primary hepatocarcinoma (right lobe of the liver), III phase.Because cancer late period can't be excised, various the failing to respond to any medical treatment such as row chemicotherapy, allowed its 16 years old son succeed, advises speed to prepare funeral affairs.Disease progression is rapid, patient's severe pain unbearably, becoming severe at night, nausea and vomiting, do not think Na Gu, have a dizzy spell, the whole body weak, skeletonize.Look into: the cachexia work, complexion is steel gray, and red network is abound with, die Blausucht, upper right Fu Disorder piece bulge, exceed finned surface 3cm, and about the liver upper bound the 3rd intercostal, the flat umbilicus of lower bound, two limbs circle are unclear, abdominal tympanites, lump matter is hard, the edge irregular, and surface is uneven, and tuberosity is large as fist, little of Semen Juglandis, as hard as flint, what push away does not move, the tenderness work, 3cm under the spleen rib, 10 fingernail stripeds are coarse, be uneven, 8 fingernails separate fully with nail matrix, and color is purple dark.Touch the large lymph node of Semen Juglandis on left clavicle, surface is extremely rough, the hard inertia of matter.Two lungs are heard and moist rales.Western medicine diagnose: advanced primary lobus dexter hepatocarcinoma, lung and left clavicle superior gluteal lymph node shift.After the Chinese medicine composition that is used for the treatment of hepatocarcinoma provided through the embodiment of the present invention 1 is distinguished and controlled, hepatalgia disappears, and starts to think food, and the lump tuberosity starts deliquescing to be dwindled, and formerly exceeds lump on finned surface lower than under rib, and metastatic lymph node disappears.In therapeutic process, the change of illness state multiterminal, go through hardships treatment in 3 years, make it to pull through again and again, then the traditional Chinese medicine composition for treating that is used for the treatment of hepatocarcinoma provided with the embodiment of the present invention 2, final all illness are known and are removed, incurable disease must heal, always in Bricks and Tiles Plant's work, healthy and strong after retirement, be good for and deposit more than 40 years so far.
Case 2 poplars, female, 37 years old, first visit on November 17 in 1971.The main suit: abdominal distention stomachache, the food of receiving not to advance, and by transfusion, sustain life more than January.Right flank severe pain before half a year, abdominal distention can't be worked, and once runs the whole province's various big hospital to check comprehensively, all is diagnosed as primary hepatocarcinoma (right lobe of the liver), the III phase.Because being later period of hepatocarcinoma, the various treatments of row are all invalid, finally allow and go home to prepare funeral affairs.More than month, come hepatic region severe pain as lancinated, kneel night on daytime and withstand hepatic region in edge of bed and still can't delay pain, play the dolantin pain relieving every day, after also lost efficacy, because standing hepatocarcinoma severe pain, commit suicide 6 times, because 5 children cry bitterly, its lover saves her.One wheat harvesting period is not taken even a drop of water, and by transfusion, sustains life, real overwhelmed with sorrow.Look into: the cachexia work, face is steel gray, worn to a shadow, full tripe ascites, one's belly is tight as a drum, cries bitterly more than, the Chinese medicine composition that is used for the treatment of hepatocarcinoma provided through the embodiment of the present invention 1 is distinguished and is controlled, and rushes down lower a large amount of stick shape black thing after medicine, and Teng Tong ﹑ cough alleviates, gradually can take food, the rescue of trying one's best, pull through at last, the traditional Chinese medicine composition for treating that is used for the treatment of hepatocarcinoma provided with the embodiment of the present invention 4 again, severe and lingering illness plays incurable disease more, healthy living work always after recovery from illness, strong depositing more than 40 years so far.
Case 3 Qin, man, 51 years old, first visit on April 15 in 1980.Main suit: more than hepatic region persistence severe pain January.Doctor trained in Western medicine is diagnosed as primary hepatocarcinoma (right lobe of liver), III phase.Make progress rapidly through the uncontrollable state of an illness of various big hospital diagnosis and treatment, repeatedly look into the AFP(alpha-fetoprotein) significantly raise and constantly continue and rise.Patient hepatic region persistence severe pain, movable rear pain is more acute, presses hepatic region with slightly slow severe pain with hands all day, in the afternoon has a fever more than 38 degree, and pain more very, is lain awake all night at nightfall, the tending to vomit of feeling sick, the food difficulty of receiving is advanced, and becomes thin unable, and uncomfortable in chest easypro, stool is lost smooth.Look into: be cachexia, 3cm under right rib, 9cm under xiphoid-process, matter is hard, and it is smooth that owe on surface, and edge is irregular, the tenderness work, spleen transverse diameter 14cm, the nail surface striped is coarse, two thumb first significant depressions.The patient has chronic hepatitis, pulmonary tuberculosis, pyelonephritis history.After the Chinese medicine composition that is used for the treatment of hepatocarcinoma provided through the embodiment of the present invention 1 is distinguished and is controlled, the state of an illness is got better and is turned greatly, feel cold fever only, the hepatic region alleviation of pain, abdominal distention is alleviated, the traditional Chinese medicine composition for treating that is used for the treatment of hepatocarcinoma of taking medicine after more than 400 agent and providing with the embodiment of the present invention 3 again, make eventually incurable disease accuse more, be back on the job, full-time job, the AFP(alpha-fetoprotein), always within normal range, followed up a case by regular visits to strong depositing more than 27 years to 2007.
Case 4 Chens, man, 49 years old, first visit on March 8 in 1981.The main suit: abdominal distention stomachache increases the weight of more than February half a year.Rib jumping pain half a year in right season, pain dimensions constantly enlarges, and enters nyctalgia very, can't fall asleep, and to the various big hospital diagnosis and treatment, all is diagnosed as primary hepatocarcinoma (right lobe of the liver), the III phase.Once treated to many places after making a definite diagnosis hepatocarcinoma, and take traditional Chinese medicine hundreds of doses, but uncontrollable disease progression is repeatedly looked into the AFP(alpha-fetoprotein) all reach 1000ug/L more than, and constantly continue to raise.Over month often in night fever, dysphoria, abdominal distention unbearably, nausea and vomiting, stomach is received extreme difference, become thin unable, the cancer pain aggravation, the state of an illness worsens rapidly.Look into: the cachexia work, greenish-yellow complexion, skin is withered, 3cm under the right rib of liver, 5cm under xiphoid-process, matter is hard, and surface is uneven, and edge is irregular, and tenderness is obvious, spleen transverse diameter 16cm, liver palm is obvious, the coarse attenuation of nail surface striped.The patient has serious gastroptosis history.After the Chinese medicine composition that is used for the treatment of hepatocarcinoma provided through the embodiment of the present invention 1 is distinguished and is controlled, the traditional Chinese medicine composition for treating that is used for the treatment of hepatocarcinoma provided with the embodiment of the present invention 5 again, AFP is down to normally gradually, all illness are known and are removed, whole beginning persistent ailment must heal, after recovering on construction site physical work, strong depositing more than 30 years.
Case 5 fourths, the man, 48 years old, within 2011, JIUYUE was examined on the 2nd.Main suit: more than hepatic region severe pain companion jaundice January.On May 7th, 2010, unexpected epigastrium had an intense pain, with the gastropathy diagnosis and treatment, jaundice appears after first quarter moon, B ultrasonic is found the leftlobe of liver occupy-place, be in hospital in the academician of the Chinese Academy of Sciences Wu Mengchao expert lesion that go to east hospital of Genneral Surgery of Shanghai The 2nd Army Medical College, National Top Science and Technology Award winner, is described as " father of Chinese Genneral Surgery ", look into the AFP(alpha-fetoprotein) be 17235ug/L, in capable leftlobe of liver RESECTION OF LIVER CANCER on May 13, see approximately 6 * 5cm of corpus carcinosus out-of-shape
2, obscure boundary, without peplos, peripheral sub-kitchen range, cancer embolus is seen by bile duct branch.Postoperative AFP is down to 73.9ug/L, and discharge diagnosis is: 1. primary hepatocarcinoma (left liver leaf), 2. hepatitis B virus carriers, 3. posthepatitic cirrhosis.Pathological diagnosis: the thick beam type of hepatocarcinoma, the III level, brief summary nodal pattern liver cirrhosis, tumor is diffusion-type, many nodositas growths, visible cancer embolus in blood vessel.After Liver Cancer Operation, more than the moon, in the super academician expert of the east Wu Meng of hospital of Genneral Surgery of Shanghai The 2nd Army Medical College lesion, be in hospital for the second time again, the preventative chemotherapy of hepatocellular carcinoma perfusion of row adds Embolization.After Liver Cancer Operation, to check AFP be 446ug/L April, looks into and see liver cancer recurrence.Within 2010, JIUYUE goes to again the Shanghai second east hospital of Genneral Surgery of medical university of army at the super academician of national famous hepatocarcinoma expert Wu Meng place to seek medical advice for the third time on the 20th, doctor accuses this patient's prognosis mala of its family members, without good method treatment, helplessly forward many large hospital hospitalization to from Shanghai, all be diagnosed as Postoperative Recurrent Hepatocellular Carcinoma and gastroscope and show gastric antrum section ulcer, duodenal bulbar ulcer, the distortion of ball chamber.Though the while in hospital is used up the whole bag of tricks treatment, AFP continues to raise, reached once 500GY/ the treatment of gamma knife of 9 times, uncontrollable cancerous protuberance still, successively carry out Shengmai injection 3 times again, again the various advanced Therapeutic Method Comprehensive Treatments such as tumor injection art and Biotherapeutics, all uncontrollable disease progression in percutaneous puncture liver repeatedly, liver cirrhosis accompanies multiple regenerated nodule to be on the increase, and splenomegaly occurs.Look into CT on July 29th, 2011: multiple low-density lesser tubercle in liver, before increase, Intrahepatic Bile Duct Dilation, reach axillary fossa in vertical diaphragm and see multiple lymph node, bilateral clavicle form and density anomaly.While in hospital, once the percutaneous TACE was repeatedly again, and repeatedly carry out again tumor injection art in the percutaneous puncture liver, but AFP always constantly raises, liver cirrhosis with regenerating node is on the increase, the transaminase also obviously raises, therefore carry out again in the percutaneous puncture liver tumor radio-frequency ablation procedure twice under general anesthesia, be in hospital 7 times altogether in front and back, after leaving hospital, with Traditional Chinese Medicine Fuzheng, treat at every turn, but master control does not live the lasting rising of AFP, new hepatocarcinoma tuberosity constantly produces, and jaundice constantly increases the weight of, liver cirrhosis with regenerating node also is on the increase, because real can't standing repeatedly carried out under general anesthesia repeatedly tumor radio-frequency ablation procedure in the percutaneous puncture liver and left hospital, but because AFP continues to raise, and occur that obstructive jaundice can only prepare the logical biliary surgery of row support, but eventually because being short of physical strength, receive anorexia, overall health of patients is poor and can't tolerate surgery and do not treat again.The patient goes through torment, and pessimistic desperate, the state of an illness sharply worsens, the hepatocarcinoma diffusion transfer, and obstructive jaundice progress aggravation, and ascites appears, while examining, the state of an illness is dangerous.The Chinese medicine composition that is used for the treatment of hepatocarcinoma provided through the embodiment of the present invention 1 is distinguished and is controlled, rescue with all strength, finally pull through, get better and turn greatly through the treatment patient's condition, the check nuclear magnetic resonance, NMR shows that former two hepatocarcinoma tuberositys need again doing tumor radio-frequency ablation procedure in the percutaneous puncture liver disappear, liver cirrhosis with regenerating node obviously dwindles, bile duct is also unobstructed, and (original cancer embolus disappears, without doing again the unimpeded bile duct of support), AFP also descends gradually, jaundice disappears, ascites disappears substantially, liver function approaches normal, gastric antrum section ulcer, duodenal bulbar ulcer also heals, the patient is without any discomfort at present, food is slept all good, energetic, strong as ordinary person, can drive to play everywhere, still in continual cure, the patient is full of confidence, believe firmly and must thoroughly defeat the existence of cancer enemy long-term health.
Claims (4)
1. a Chinese medicine composition that is used for the treatment of hepatocarcinoma, is characterized in that, by the crude drug of following parts by weight, made:
Radix Angelicae Sinensis 24-40 part RADIX CURCUMAE from Sichuan of China 9-21 part Radix Bupleuri 9-21 part Flos Albiziae 15-30 part
Radix Paeoniae Alba 15-30 part herba lycopi 20-40 part Radix Astragali 30-90 part Radix Pseudostellariae 30-60 part
Rhizoma Atractylodis Macrocephalae (parched) 20-40 part Semen Coicis 40-90 part Pericarpium Citri Reticulatae 9-15 part Rhizoma Pinelliae 9-15 part
Rhizoma Paridis 30-90 part Herba Portulacae 30-90 part Rhizoma Smilacis Glabrae 40-90 part Herba Solani Nigri 20-40 part
Nidus Vespae 30-60 part Herba Lobeliae Chinensis 30-60 part Herba Hedyotidis Diffusae 40-90 part Herba Artemisiae Anomalae 7-18 part
Radix Cynanchi Paniculati 15-40 part Carapax Trionycis (processed with vinegar) 30-50 part Concha Arcae 30-60 part Herba Salviae Chinensis 15-40 part
Rhizoma Curcumae 9-30 part Semen Pharbitidis 20-40 part Fructus Aurantii 9-15 part Fructus Aurantii Immaturus 9-15 part
Herba Epimedii 9-18 part Radix Rehmanniae 7-12 6～12 parts of Radix Notoginseng powder of part (taking after mixing it with water).
2. the Chinese medicine composition that is used for the treatment of hepatocarcinoma according to claim 1, is characterized in that, by the crude drug of following parts by weight, made:
Radix Angelicae Sinensis 30-35 part RADIX CURCUMAE from Sichuan of China 12-18 part Radix Bupleuri 12-18 part Flos Albiziae 20-30 part
Radix Paeoniae Alba 15-20 part herba lycopi 30-40 part Radix Astragali 35-60 part Radix Pseudostellariae 35-50 part
Rhizoma Atractylodis Macrocephalae (parched) 30-40 part Semen Coicis 50-70 part Pericarpium Citri Reticulatae 10-12 part Rhizoma Pinelliae 10-12 part
Rhizoma Paridis 35-60 part Herba Portulacae 30-60 part Rhizoma Smilacis Glabrae 40-70 part Herba Solani Nigri 30-40 part
Nidus Vespae 30-50 part Herba Lobeliae Chinensis 30-50 part Herba Hedyotidis Diffusae 40-80 part Herba Artemisiae Anomalae 9-15 part
Radix Cynanchi Paniculati 30-40 part Carapax Trionycis (processed with vinegar) 35-40 part Concha Arcae 35-50 part Herba Salviae Chinensis 15-30 part
Rhizoma Curcumae 12-30 part Semen Pharbitidis 30-40 part Fructus Aurantii 10-12 part Fructus Aurantii Immaturus 10-12 part
Herba Epimedii 12-15 part Radix Rehmanniae 7-10 6～9 parts of Radix Notoginseng powder of part (taking after mixing it with water).
3. the Chinese medicine composition that is used for the treatment of hepatocarcinoma according to claim 2, is characterized in that, by the crude drug of following parts by weight, made:
30 parts of 12 parts of Flos Albiziaes of 12 parts of Radix Bupleuri of 30 parts of RADIX CURCUMAE from Sichuan of China of Radix Angelicae Sinensis
35 parts of 40 parts of Radix Pseudostellariaes of 30 parts of Radixs Astragali of 15 parts of herba lycopis of the Radix Paeoniae Alba
10 parts of 10 parts of Rhizoma Pinelliaes of 50 parts of Pericarpium Citri Reticulataes of 30 parts of Semen Coiciss of Rhizoma Atractylodis Macrocephalae (parched)
30 parts of 60 portions of Herba Solani Nigris of 40 parts of Rhizoma Smilacis Glabraes of 35 portions of Herba Portulacaes of Rhizoma Paridis
15 parts of 40 parts of Herba Artemisiae Anomalaes of 30 parts of Herba Hedyotidis Diffusaes of 30 portions of Herba Lobeliae Chinensis of Nidus Vespae
15 parts of 35 parts of Herba Salviae Chinensiss of 40 parts of Concha Arcaes of 30 parts of Carapax Trionycis (processed with vinegar) of Radix Cynanchi Paniculati
10 parts of 10 parts of Fructus Aurantii Immaturuss of 30 parts of Fructus Aurantiis of 15 parts of Semen Pharbitidis of Rhizoma Curcumae
Herba Epimedii 7 parts of 7 parts of Radix Notoginseng powder of 15 parts of Radix Rehmanniae (taking after mixing it with water).
4. according to the described Chinese medicine composition that is used for the treatment of hepatocarcinoma of claim 1-3 any one, it is characterized in that, the described Chinese medicine composition that is used for the treatment of hepatocarcinoma is any in decoction, watered pill, capsule, powder, oral liquid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012103939544A CN102920977B (en) | 2012-10-12 | 2012-10-12 | Traditional Chinese medicine composition for treating liver cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012103939544A CN102920977B (en) | 2012-10-12 | 2012-10-12 | Traditional Chinese medicine composition for treating liver cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102920977A CN102920977A (en) | 2013-02-13 |
| CN102920977B true CN102920977B (en) | 2013-12-18 |
Family
ID=47636002
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012103939544A Expired - Fee Related CN102920977B (en) | 2012-10-12 | 2012-10-12 | Traditional Chinese medicine composition for treating liver cancer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102920977B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115300575B (en) * | 2021-05-08 | 2023-06-30 | 首都医科大学附属北京地坛医院 | Traditional Chinese medicine composition for liver cancer related to hepatitis B |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101716280A (en) * | 2009-12-23 | 2010-06-02 | 刘建国 | Medicine composite used for curing liver cancer |
| CN101757598A (en) * | 2009-11-05 | 2010-06-30 | 泰一和浦（北京）中医药研究院有限公司 | Traditional Chinese medicine composition for treating advanced malignant liver tumor symptoms and preparation method thereof |
| CN101757562A (en) * | 2009-11-05 | 2010-06-30 | 泰一和浦（北京）中医药研究院有限公司 | Traditional Chinese medicine composition for treating mid-term malignant liver tumor symptoms and preparation method thereof |
| CN102626508A (en) * | 2012-04-24 | 2012-08-08 | 山东大学齐鲁医院 | Traditional Chinese medicine composite for curing liver cancer |
-
2012
- 2012-10-12 CN CN2012103939544A patent/CN102920977B/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101757598A (en) * | 2009-11-05 | 2010-06-30 | 泰一和浦（北京）中医药研究院有限公司 | Traditional Chinese medicine composition for treating advanced malignant liver tumor symptoms and preparation method thereof |
| CN101757562A (en) * | 2009-11-05 | 2010-06-30 | 泰一和浦（北京）中医药研究院有限公司 | Traditional Chinese medicine composition for treating mid-term malignant liver tumor symptoms and preparation method thereof |
| CN101716280A (en) * | 2009-12-23 | 2010-06-02 | 刘建国 | Medicine composite used for curing liver cancer |
| CN102626508A (en) * | 2012-04-24 | 2012-08-08 | 山东大学齐鲁医院 | Traditional Chinese medicine composite for curing liver cancer |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102920977A (en) | 2013-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102342992B (en) | Chinese medicinal composition for treating insomnia and preparation method of preparation thereof | |
| CN102847064A (en) | Chinese herbal medicine used for inhibition of malignant tumor metastasis | |
| CN101249243B (en) | Chinese medicine for curing acute leukemia | |
| CN105213974A (en) | One treats lymphadenomatous Chinese medicine composition and application thereof | |
| CN105012735B (en) | One kind fills blood anticancer traditional Chinese medicinal composition | |
| CN101007159B (en) | Traditional Chinese medicine for preventing and controlling tumor | |
| CN102940815A (en) | Medicine prescription for treating tuberculosis and tuberculous rheumatism | |
| CN103285343B (en) | Medicine for treating liver cancer and preparation method thereof | |
| CN102920977B (en) | Traditional Chinese medicine composition for treating liver cancer | |
| CN102526631B (en) | Traditional Chinese medicine preparation, tablet and capsule for curing dilated cardiomyopathy and preparation method | |
| CN102671056B (en) | Chinese medicinal composition for treating hepatitis and preparation method thereof | |
| CN105055967A (en) | Compound health care product having auxiliary blood sugar reducing function and preparation method | |
| CN102631449B (en) | Chinese medicinal composition for treating acute pancreatitis | |
| CN111407872A (en) | Traditional Chinese medicine composition for treating liver cancer, medicine for treating liver cancer and preparation method of medicine | |
| CN100409852C (en) | Chinese medicine for enhancing immunologic function | |
| CN104116908A (en) | A traditional Chinese medicine decoction for treating arrhythmia | |
| CN104189615B (en) | Traditional Chinese medicine preparation for treating metrorrhagia and metrostaxis, and preparation method of traditional Chinese medicine preparation | |
| CN102961704A (en) | Pharmaceutical composition for treating liver caner and method for preparing dispersible tablets thereof | |
| CN103285130B (en) | Chinese medicine composition for liver cancer treatment and preparing method thereof | |
| CN102671111B (en) | Chinese medicinal composition for treating malignant soft tissue neoplasm | |
| CN102430054B (en) | Applications of traditional Chinese medicinal compound preparation for removing toxicity, resisting cancer, activating blood and dissipating mass | |
| CN102240384B (en) | Medicament for treating phlegm-stasis accumulating type epilepsy and preparation method thereof | |
| CN106389967A (en) | Medicine for treating neurasthenia and preparation method thereof | |
| CN106389598A (en) | Traditional Chinese medicine composition for curing purpura | |
| CN105213967A (en) | A kind of Chinese medicine preparation for the treatment of malignant tumor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131218 Termination date: 20181012 |